scispace - formally typeset
Open AccessJournal ArticleDOI

IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist

Reads0
Chats0
TLDR
Evidence is provided that IL-38 binds to theIL-36R, as does IL-36Ra, and that IL -38 and IL- 36Ra have similar biological effects on immune cells by engaging the IL-37 receptor.
Abstract
The functional role of IL-1 family member 10, recently renamed IL-38, remains unknown. In the present study we aimed to elucidate the biological function of IL-38 and to identify its receptor. Heat-killed Candida albicans was used to stimulate memory T-lymphocyte cytokine production in freshly obtained human peripheral blood mononuclear cells from healthy subjects. The addition of recombinant IL-38 (152 amino acids) inhibited the production of T-cell cytokines IL-22 (37% decrease) and IL-17 (39% decrease). The reduction in IL-22 and IL-17 caused by IL-38 was similar to that caused by the naturally occurring IL-36 receptor antagonist (IL-36Ra) in the same peripheral blood mononuclear cells cultures. IL-8 production induced by IL-36γ was reduced by IL-38 (42% decrease) and also was reduced by IL-36Ra (73% decrease). When human blood monocyte-derived dendritic cells were used, IL-38 as well as IL-36Ra increased LPS-induced IL-6 by twofold. We screened immobilized extracellular domains of each member of the IL-1 receptor family, including the IL-36 receptor (also known as “IL-1 receptor-related protein 2”) and observed that IL-38 bound only to the IL-36 receptor, as did IL-36Ra. The dose–response suppression of IL-38 as well as that of IL-36Ra of Candida-induced IL-22 and IL-17 was not that of the classic IL-1 receptor antagonist (anakinra), because low concentrations were optimal for inhibiting IL-22 production, whereas higher concentrations modestly increased IL-22. These data provide evidence that IL-38 binds to the IL-36R, as does IL-36Ra, and that IL-38 and IL-36Ra have similar biological effects on immune cells by engaging the IL-36 receptor.

read more

Citations
More filters
Journal ArticleDOI

The Interleukin-1 Family: Back to the Future

TL;DR: The key properties of IL-1 family members are reviewed, with emphasis on pathways of negative regulation and orchestration of innate and adaptive immunity.
Journal ArticleDOI

Overview of the IL-1 family in innate inflammation and acquired immunity.

TL;DR: Although the inflammatory properties of the IL‐1 family dominate in innate immunity, IL‐2 family member can play a role in acquired immunity and this overview is a condensed update.
Journal ArticleDOI

Interleukin-22: Immunobiology and Pathology

TL;DR: The current understanding of IL-22 is assessed, including its physiologic and pathologic effects on epithelial cell function, which are linked to several conditions involving inflammatory tissue pathology.
Journal ArticleDOI

The interleukin (IL)-1 cytokine family--Balance between agonists and antagonists in inflammatory diseases

TL;DR: Several genetic modifications or mutations associated with dysregulated IL-1 activity and autoinflammatory disorders were identified in mouse models and in patients and paved the road to the successful use of IL- 1 inhibitors in diseases that were previously considered as untreatable.
Journal ArticleDOI

Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease

TL;DR: There is overwhelming evidence linking the NLRP3 inflammasome and the IL-1 cytokines with the pathogenetic role of atherosclerosis, in ischemic (acute myocardial infarction), and nonischemic injury to the myocardium (myocarditis) and the progression to heart failure.
References
More filters
Journal ArticleDOI

Interleukin-1 in the pathogenesis and treatment of inflammatory diseases

TL;DR: This review summarizes acute and chronic inflammatory diseases that are treated by reducing IL-1β activity and proposes that disease severity is affected by the anti-inflammatory members of the IL- 1 family of ligands and receptors.
Journal ArticleDOI

IL-22 increases the innate immunity of tissues.

TL;DR: IL-22 does not serve the communication between immune cells but is a T cell mediator that directly promotes the innate, nonspecific immunity of tissues.
Journal ArticleDOI

Interleukin-18 Binding Protein: A Novel Modulator of the Th1 Cytokine Response

TL;DR: Interleukin-18 binding protein functions as an inhibitor of the early Th1 cytokine response, suggesting that viral products may attenuate IL-18 and interfere with the cytotoxic T cell response.
Related Papers (5)